Business ❯ Healthcare ❯ Biotechnology

Drug Development

Clinical Trials Colorectal Cancer Clinical Testing Vaccine Approval FDA Approval Autoimmune Diseases CGT9486 Lab Equipment Renal Diseases Cushing's Syndrome Treatments Viking Therapeutics Immunology Zymeworks Inc. Chronic Diseases GLP-1 Weight Loss Drugs Market Trends

Kailera Leaps 62% in Nasdaq Debut After $625 Million IPO

The strong debut signals renewed investor interest in obesity drugs.

AnaptysBio Seeks to Toss Tesaro Anticipatory‑Breach Claim in Jemperli Royalty Dispute

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion